List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Macular Edema Therapeutics Revenue in Macular Edema Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Macular Edema Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Macular Edema Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Macular Edema Therapeutics Market Size for the Year 2017-2028
1.3 Macular Edema Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Macular Edema Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Macular Edema Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Macular Edema Therapeutics Market Dynamics
1.4.1 Macular Edema Therapeutics Industry Trends
1.4.2 Macular Edema Therapeutics Market Drivers
1.4.3 Macular Edema Therapeutics Market Challenges
1.4.4 Macular Edema Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Macular Edema Therapeutics by Type
2.1 Macular Edema Therapeutics Market Segment by Type
2.1.1 Laser Treatment
2.1.2 Anti-VEGF Injection
2.1.3 Anti-Inflammatory Treatment
2.1.4 Vitrectomy
2.2 Global Macular Edema Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Macular Edema Therapeutics Market Size by Type (2017-2028)
2.4 United States Macular Edema Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Macular Edema Therapeutics Market Size by Type (2017-2028)
3 Macular Edema Therapeutics by Application
3.1 Macular Edema Therapeutics Market Segment by Application
3.1.1 Cystoid Macular Edema (CME)
3.1.2 Diabetic Macular Edema(DME)
3.2 Global Macular Edema Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Macular Edema Therapeutics Market Size by Application (2017-2028)
3.4 United States Macular Edema Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Macular Edema Therapeutics Market Size by Application (2017-2028)
4 Global Macular Edema Therapeutics Competitor Landscape by Company
4.1 Global Macular Edema Therapeutics Market Size by Company
4.1.1 Top Global Macular Edema Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Macular Edema Therapeutics Revenue by Player (2017-2022)
4.2 Global Macular Edema Therapeutics Concentration Ratio (CR)
4.2.1 Macular Edema Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Macular Edema Therapeutics in 2021
4.2.3 Global Macular Edema Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Macular Edema Therapeutics Headquarters, Revenue in Macular Edema Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Macular Edema Therapeutics Headquarters and Area Served
4.3.2 Global Macular Edema Therapeutics Companies Revenue in Macular Edema Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Macular Edema Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Macular Edema Therapeutics Market Size by Company
4.5.1 Top Macular Edema Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Macular Edema Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Macular Edema Therapeutics Market Size by Region
5.1 Global Macular Edema Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Macular Edema Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Macular Edema Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Macular Edema Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Macular Edema Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Macular Edema Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Macular Edema Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Macular Edema Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Macular Edema Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Macular Edema Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Macular Edema Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Macular Edema Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Macular Edema Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Macular Edema Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Allergan
7.1.1 Allergan Company Details
7.1.2 Allergan Business Overview
7.1.3 Allergan Macular Edema Therapeutics Introduction
7.1.4 Allergan Revenue in Macular Edema Therapeutics Business (2017-2022)
7.1.5 Allergan Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis Macular Edema Therapeutics Introduction
7.2.4 Novartis Revenue in Macular Edema Therapeutics Business (2017-2022)
7.2.5 Novartis Recent Development
7.3 Roche
7.3.1 Roche Company Details
7.3.2 Roche Business Overview
7.3.3 Roche Macular Edema Therapeutics Introduction
7.3.4 Roche Revenue in Macular Edema Therapeutics Business (2017-2022)
7.3.5 Roche Recent Development
7.4 Regeneron Pharmaceuticals
7.4.1 Regeneron Pharmaceuticals Company Details
7.4.2 Regeneron Pharmaceuticals Business Overview
7.4.3 Regeneron Pharmaceuticals Macular Edema Therapeutics Introduction
7.4.4 Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2017-2022)
7.4.5 Regeneron Pharmaceuticals Recent Development
7.5 Pfizer
7.5.1 Pfizer Company Details
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Macular Edema Therapeutics Introduction
7.5.4 Pfizer Revenue in Macular Edema Therapeutics Business (2017-2022)
7.5.5 Pfizer Recent Development
7.6 Bayer
7.6.1 Bayer Company Details
7.6.2 Bayer Business Overview
7.6.3 Bayer Macular Edema Therapeutics Introduction
7.6.4 Bayer Revenue in Macular Edema Therapeutics Business (2017-2022)
7.6.5 Bayer Recent Development
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Details
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Macular Edema Therapeutics Introduction
7.7.4 Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2017-2022)
7.7.5 Boehringer Ingelheim Recent Development
7.8 Bausch & Lomb
7.8.1 Bausch & Lomb Company Details
7.8.2 Bausch & Lomb Business Overview
7.8.3 Bausch & Lomb Macular Edema Therapeutics Introduction
7.8.4 Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2017-2022)
7.8.5 Bausch & Lomb Recent Development
7.9 Aciont
7.9.1 Aciont Company Details
7.9.2 Aciont Business Overview
7.9.3 Aciont Macular Edema Therapeutics Introduction
7.9.4 Aciont Revenue in Macular Edema Therapeutics Business (2017-2022)
7.9.5 Aciont Recent Development
7.10 ActiveSite Pharmaceuticals
7.10.1 ActiveSite Pharmaceuticals Company Details
7.10.2 ActiveSite Pharmaceuticals Business Overview
7.10.3 ActiveSite Pharmaceuticals Macular Edema Therapeutics Introduction
7.10.4 ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2017-2022)
7.10.5 ActiveSite Pharmaceuticals Recent Development
7.11 Adverum Biotechnologies
7.11.1 Adverum Biotechnologies Company Details
7.11.2 Adverum Biotechnologies Business Overview
7.11.3 Adverum Biotechnologies Macular Edema Therapeutics Introduction
7.11.4 Adverum Biotechnologies Revenue in Macular Edema Therapeutics Business (2017-2022)
7.11.5 Adverum Biotechnologies Recent Development
7.12 Aerpio Therapeutics
7.12.1 Aerpio Therapeutics Company Details
7.12.2 Aerpio Therapeutics Business Overview
7.12.3 Aerpio Therapeutics Macular Edema Therapeutics Introduction
7.12.4 Aerpio Therapeutics Revenue in Macular Edema Therapeutics Business (2017-2022)
7.12.5 Aerpio Therapeutics Recent Development
7.13 Ampio Pharmaceuticals
7.13.1 Ampio Pharmaceuticals Company Details
7.13.2 Ampio Pharmaceuticals Business Overview
7.13.3 Ampio Pharmaceuticals Macular Edema Therapeutics Introduction
7.13.4 Ampio Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2017-2022)
7.13.5 Ampio Pharmaceuticals Recent Development
7.14 Araim Pharmaceuticals
7.14.1 Araim Pharmaceuticals Company Details
7.14.2 Araim Pharmaceuticals Business Overview
7.14.3 Araim Pharmaceuticals Macular Edema Therapeutics Introduction
7.14.4 Araim Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2017-2022)
7.14.5 Araim Pharmaceuticals Recent Development
7.15 Astellas Pharma
7.15.1 Astellas Pharma Company Details
7.15.2 Astellas Pharma Business Overview
7.15.3 Astellas Pharma Macular Edema Therapeutics Introduction
7.15.4 Astellas Pharma Revenue in Macular Edema Therapeutics Business (2017-2022)
7.15.5 Astellas Pharma Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
